Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Immunocore Holdings Limited
Immunocore to present at upcoming investor conferences
April 04, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore presented two posters at CROI 2024
March 05, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to present at upcoming investor conferences
March 01, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
February 28, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial
February 22, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024
February 21, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore Prices Upsized Convertible Senior Notes Offering
January 30, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore Announces Proposed Convertible Senior Notes Offering
January 29, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
January 05, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update
November 07, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023
November 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to present at upcoming investor conferences
October 30, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial
October 21, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore announces upcoming presentation and posters at ESMO 2023
October 06, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to present at upcoming investor conferences
September 11, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to present at upcoming investor conferences
September 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to report second quarter 2023 financial results and host call on August 10, 2023
August 03, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
June 03, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to present at upcoming investor conferences
June 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to present at the Bank of America Securities 2023 Health Care Conference
May 03, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
April 18, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to present four posters at AACR Annual Meeting 2023
March 14, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore Reports 2022 Financial Results and Provides Business Update
March 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to present at upcoming investor conferences
February 28, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
February 23, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
February 22, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Tickers
IMCR
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
